The Food and Drug Administration approved Epix Pharmaceuticals Inc.'s (Nasdaq: EPIX) magnetic resonance angiography blood vessel imaging agent Vasovist sending the stock price soaring 46 cents to close at $1.66.
FDA Approves Epix's Vasovist
December 23, 2008 at 17:44 PM EST
